NCT07415031 2026-04-08A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib StudiesMirati Therapeutics Inc.Phase 2 Not yet recruiting170 enrolled
NCT05853575 2026-03-27Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)Mirati Therapeutics Inc.Phase 2 Active not recruiting200 enrolled